KELSEY BARGER: Open Payments
NPI 1104336924 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 42 payments from 14 companies in 2025. Trend: 2023 $347 · 2024 $1,450 · 2025 $1,026
Food & beverage: $926Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $335 |
| Janssen Biotech, Inc. | 5 | $177 |
| Amgen Inc. | 10 | $158 |
| UCB, Inc. | 5 | $114 |
| Genentech USA, Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Almatica Pharma LLC | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Organon LLC | 1 | $20 |
Products named: RINVOQ, TREMFYA, Bimzelx, SKYRIZI, TAVNEOS, COSENTYX, OTEZLA, Gazyva.
Industry payments across IA — which companies pay providers there.
